本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

13.60
-0.1700-1.23%
盘后13.600.00000.00%17:53 EDT
成交量:61.11万
成交额:826.89万
市值:6.76亿
市盈率:-3.65
高:13.91
开:13.89
低:13.28
收:13.77
数据加载中...
2022/07/07

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/07/07

重要事件披露

8-K - Current report
2022/05/27

重要事件披露

8-K - Current report
2022/05/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership